No conviction changes recorded
Upgrade to premium to see the full reasoning behind each conviction change.
Sign in to unlockFair Value Distribution — percentile bands
100.0% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
0.1%/yr
±12.4% · revenue growth to justify current price
Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.
Sign in to unlockCentene Medicaid managed care; redetermination headwinds fading; state contract wins.
Medicaid acuity surprise risk; state budget pressures; CMS audit exposure.
Updated Apr 7
Q4 2025 trends consistent with expectations, slightly favorable in Marketplace. 2026 guidance: adj EPS >.00 at ~11x on stock; Medicaid revenue declining B from redetermination; HBR improving 60 bps o...
Centene faces convergence of structural headwinds: Medicaid member acuity rising, Marketplace risk pool deteriorating, Medicare pricing inadequate, balance sheet impaired. Corrective pricing actions u...